DRKS00010430CompletedNot Applicable
Bone density assessment in patients with partial-onset epileptic seizures - BONAPARTE
niversitätsklinikum FreiburgEpilepsiezentrum0 sites26 target enrollmentStarted: October 6, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 26
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •1.Male and female patients = 18 years of age;
- •2.Patients with partial-onset seizures with or without secondary generalization;
- •3.Treatment with eslicarbazepine-acetate;
- •4.Written informed consent to participate in the trial and ability to adhere to the protocol
Exclusion Criteria
- •1.Comedication with phenobarbitone, primidone, carbamazepine, phenytoin, oxcarbazepine, valproate, corticosteroids;
- •2.Known pregnancy or planned pregnancy;
- •3.Immobilized patients;
- •4.Preexisting bone disease
Investigators
Similar Trials
Completed
Phase 3
Bone density changes before and after administration of danozoomabIRCT20210803052067N1Artesh University of Medical Sciences202
Active, not recruiting
Phase 1
study to assess the changes in bone health after changing from a TDF based regimen to Bicetegravir-Tenofovir Alafenamide-Emtricitavine based treatmentEUCTR2018-004499-36-ESConsorci Mar Parc de Salut de Barcelona60
Recruiting
Phase 2
evaluation of dental implant 3ASingle edentulous or three-unit bridge.Complete loss of teethK08.1IRCT20210802052053N2Tehran University of Medical Sciences76
Recruiting
Phase 2
evaluation of dental implant AvitaIRCT20210802052053N1Tehran University of Medical Sciences76
Not yet recruiting
Phase 2
Effect of 1% Metformin gel on bone density.CTRI/2024/05/067922Dr Tushar Mohata